BioNTech SE (BNTX) FCF Margin Growth (1y) (2020 - 2025)
BioNTech SE (BNTX) FCF Margin Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | BioNTech SE | 21.56 Bn | 21.56 Bn | 668.28 Mn | 7,441.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7,441.00 |
| Sep 30, 2025 | 9,924.00 |
| Jun 30, 2025 | -126,661.00 |
| Mar 31, 2025 | -26,238.00 |
| Dec 31, 2024 | -9,653.00 |
| Sep 30, 2024 | -14,203.00 |
| Jun 30, 2024 | -132,270.00 |
| Mar 31, 2024 | -8,845.00 |
| Dec 31, 2023 | 4,062.00 |
| Sep 30, 2023 | -4,377.00 |
| Jun 30, 2023 | 253,106.00 |
| Mar 31, 2023 | -11,373.00 |
| Dec 31, 2022 | 1,826.00 |
| Sep 30, 2022 | 11,422.00 |
| Jun 30, 2022 | 12,244.00 |
| Mar 31, 2022 | 6,423.00 |
| Sep 30, 2021 | -25,908.00 |
| Jun 30, 2021 | -3,474.00 |
| Mar 31, 2021 | -22,022.00 |
| Sep 30, 2020 | 11,346.00 |